
Opinion|Videos|December 2, 2024
Optimizing Access in Vitiligo Treatment: Managed Care Strategies for New Therapies
Author(s)Seemal Desai, MD, FAAD
Seemal Desai, M.D., FAAD, discusses how managed care organizations can improve access to advanced vitiligo treatments through updated formulary decisions and treatment algorithms while addressing insurance coverage barriers and balancing treatment aggressiveness with value-based care considerations.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How might they affect managed care formularies and treatment algorithms?
- How do you balance the potential benefits and risks of aggressive treatment, especially in the context of value-based care?
- What are the main barriers to accessing vitiligo treatments, particularly regarding insurance coverage for advanced therapies?
- What do you recommend managed care organizations do to improve treatment access?
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
1,700 sites closed, 77,000 fewer children received PEPFAR-supported treatment after PEPFAR disruption | IAS 2026
2
Payers lean on step therapy, formulary exclusions as IRA reshapes Part D benefit design
3
Redemplo cuts triglycerides, pancreatitis risk in severe hypertriglyceridemia
4
Step therapy requirements drive up time, costs in DME patients | ASRS 2026
5























